MX342069B - Formulaciones farmacéuticas que comprenden un fosfolípido como mejorador de la penetración de un principio activo en la piel. - Google Patents
Formulaciones farmacéuticas que comprenden un fosfolípido como mejorador de la penetración de un principio activo en la piel.Info
- Publication number
- MX342069B MX342069B MX2013005306A MX2013005306A MX342069B MX 342069 B MX342069 B MX 342069B MX 2013005306 A MX2013005306 A MX 2013005306A MX 2013005306 A MX2013005306 A MX 2013005306A MX 342069 B MX342069 B MX 342069B
- Authority
- MX
- Mexico
- Prior art keywords
- phospholipid
- pharmaceutical composition
- weight
- composition
- concentration
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000003904 phospholipids Chemical class 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe una composición farmacéutica para aplicación en humanos y animales, con al menos un ingrediente activo que actúa sistémica y/o localmente, aplicable tópicamente y con al menos un fosfolipido, mejorando el transporte del ingrediente activo a través de la membrana celular y conteniendo una concentración de al menos 60% en peso de fosfatidilcolina, refiriéndose al fosfolípido. La composición muestra tal una consistencia líquida, que es capaz de rociarse como gotitas o como una espuma, mientras en la composición tal un fosfolípido se incluye, que adicionalmente contiene aceite en una concentración máxima de 7.5% en peso además de al menos 60% en peso de fosfatidilcolina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102012009575 | 2012-05-15 | ||
| DE102013004199A DE102013004199A1 (de) | 2012-05-15 | 2013-03-12 | Pharmazeutische Zusammensetzung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013005306A MX2013005306A (es) | 2013-11-26 |
| MX342069B true MX342069B (es) | 2016-09-13 |
Family
ID=47901750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013005306A MX342069B (es) | 2012-05-15 | 2013-05-10 | Formulaciones farmacéuticas que comprenden un fosfolípido como mejorador de la penetración de un principio activo en la piel. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2638894B1 (es) |
| JP (1) | JP2013237669A (es) |
| BR (1) | BR102013011801B1 (es) |
| CA (1) | CA2815477C (es) |
| CY (1) | CY1118727T1 (es) |
| DE (1) | DE102013004199A1 (es) |
| DK (1) | DK2638894T3 (es) |
| ES (1) | ES2606031T3 (es) |
| HR (1) | HRP20161318T1 (es) |
| HU (1) | HUE029793T2 (es) |
| LT (1) | LT2638894T (es) |
| MX (1) | MX342069B (es) |
| PL (1) | PL2638894T3 (es) |
| PT (1) | PT2638894T (es) |
| RS (1) | RS55291B1 (es) |
| RU (1) | RU2659943C2 (es) |
| SI (1) | SI2638894T1 (es) |
| SM (1) | SMT201600419B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10596117B1 (en) | 2014-12-31 | 2020-03-24 | Eric Morrison | Lipoleosomes as carriers for aromatic amide anesthetic compounds |
| US10561627B2 (en) | 2014-12-31 | 2020-02-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films |
| US11007161B1 (en) | 2014-12-31 | 2021-05-18 | Eric Morrison | Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2122975T3 (es) * | 1991-07-05 | 1999-01-01 | Rhone Poulenc Rorer Gmbh | Composicion fosfolipidica. |
| US6113921A (en) * | 1993-03-23 | 2000-09-05 | Pharmos Corp. | Topical and transdermal delivery system utilizing submicron oil spheres |
| DE4313402A1 (de) * | 1993-04-23 | 1994-10-27 | Hexal Pharma Gmbh | Transdermale Wirkstoffzubereitung |
| DE69434199T2 (de) * | 1993-10-07 | 2005-12-29 | Odontex, Inc., Lawrence | Absorptionsförderer für topische pharmazeutische formulierungen |
| CA2201358C (en) | 1994-09-30 | 2004-06-08 | Jurgen Regenold | Pharmaceutical composition |
| KR20070063017A (ko) * | 2004-09-24 | 2007-06-18 | 리포 케미컬즈 인크. | 국소 적용 화합물용 전달 시스템 |
| BRPI1006790B8 (pt) * | 2009-07-24 | 2021-05-25 | Mika Pharma Ges Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh | método para desenvolver uma composição farmacêutica líquida a ser aplicada na pele como uma espuma e composição adequada para uso tópico |
-
2013
- 2013-03-12 DE DE102013004199A patent/DE102013004199A1/de not_active Ceased
- 2013-03-18 ES ES13001361.8T patent/ES2606031T3/es active Active
- 2013-03-18 LT LTEP13001361.8T patent/LT2638894T/lt unknown
- 2013-03-18 EP EP13001361.8A patent/EP2638894B1/de active Active
- 2013-03-18 PL PL13001361T patent/PL2638894T3/pl unknown
- 2013-03-18 PT PT130013618T patent/PT2638894T/pt unknown
- 2013-03-18 RS RS20160854A patent/RS55291B1/sr unknown
- 2013-03-18 SI SI201330401A patent/SI2638894T1/sl unknown
- 2013-03-18 DK DK13001361.8T patent/DK2638894T3/en active
- 2013-03-18 HU HUE13001361A patent/HUE029793T2/en unknown
- 2013-05-08 JP JP2013098271A patent/JP2013237669A/ja active Pending
- 2013-05-09 CA CA2815477A patent/CA2815477C/en active Active
- 2013-05-10 RU RU2013121269A patent/RU2659943C2/ru active
- 2013-05-10 MX MX2013005306A patent/MX342069B/es active IP Right Grant
- 2013-05-13 BR BR102013011801-0A patent/BR102013011801B1/pt not_active IP Right Cessation
-
2016
- 2016-10-11 HR HRP20161318TT patent/HRP20161318T1/hr unknown
- 2016-11-14 CY CY20161101165T patent/CY1118727T1/el unknown
- 2016-11-18 SM SM201600419T patent/SMT201600419B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE029793T2 (en) | 2017-04-28 |
| JP2013237669A (ja) | 2013-11-28 |
| DK2638894T3 (en) | 2016-10-17 |
| SI2638894T1 (sl) | 2017-01-31 |
| EP2638894B1 (de) | 2016-09-14 |
| BR102013011801B1 (pt) | 2022-08-09 |
| DE102013004199A1 (de) | 2013-11-21 |
| RU2013121269A (ru) | 2014-11-20 |
| CA2815477C (en) | 2017-05-02 |
| CA2815477A1 (en) | 2013-11-15 |
| BR102013011801A2 (pt) | 2015-11-10 |
| LT2638894T (lt) | 2017-02-10 |
| RS55291B1 (sr) | 2017-03-31 |
| HRP20161318T1 (hr) | 2016-12-16 |
| ES2606031T3 (es) | 2017-03-17 |
| PT2638894T (pt) | 2016-12-13 |
| EP2638894A1 (de) | 2013-09-18 |
| RU2659943C2 (ru) | 2018-07-04 |
| PL2638894T3 (pl) | 2017-02-28 |
| SMT201600419B (it) | 2017-01-10 |
| CY1118727T1 (el) | 2017-07-12 |
| MX2013005306A (es) | 2013-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR117001A2 (es) | Formulación de premezcla de dexmedetomidina | |
| PH12015502542A1 (en) | Stabilized pemetrexed formulation | |
| PE20141297A1 (es) | Formulaciones peptidicas robustas de liberacion controlada | |
| PE20131063A1 (es) | Composicion acuosa que contiene bromhexina | |
| NZ629045A (en) | Topical compositions comprising fipronil and permethrin and methods of use | |
| AR075329A1 (es) | Composicion agroquimica estabilizada | |
| PE20080658A1 (es) | Formulaciones de metilnaltrexona en forma de polvo seco | |
| IN2014MN02288A (es) | ||
| NZ712270A (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| IN2014DN06853A (es) | ||
| SG195086A1 (en) | Compounds containing hydrido-tricyano-borate anions | |
| BR112015004185A2 (pt) | composições antiperspirantes em aerossol, produtos e métodos | |
| EA201390412A1 (ru) | Стабилизированная композиция такролимуса | |
| SG195175A1 (en) | Pesticide compositions containing thyme oil and cinnamon oil | |
| AR082155A1 (es) | Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido | |
| BR112016006171A2 (pt) | formulações de espuma e dispositivo para sua entrega | |
| UA116886C2 (uk) | Препаративна форма йодосульфурон-метилу натрієвої солі | |
| BR112015005621A2 (pt) | carbonato de hidróxido de magnésio como material veículo em preparações contendo ingredientes ativos | |
| MX2013005306A (es) | Composicion farmaceutica. | |
| AR089197A1 (es) | Composiciones cosmeticas de aceite en agua | |
| EA201291335A1 (ru) | Фармацевтические композиции для местного применения | |
| GB2519432A9 (en) | Fungicidal mixture | |
| UA109944U (uk) | Фармацевтична композиція для зниження рівня n-оксиду триметиламіну | |
| BR112015019387A2 (pt) | alimentação mineral - através de formulação | |
| TW201129660A (en) | Dermal absorption agent comprising felbinac |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |